0
0
0
Hidden Fee Disclosure Act of 2023
12/15/2023, 4:00 PM
Summary of Bill HR 4508
Bill 118 hr 4508, also known as the Hidden Fee Disclosure Act of 2023, aims to increase transparency in the financial industry by requiring companies to disclose any hidden fees to consumers. The bill was introduced in the US Congress with the goal of protecting consumers from being misled or taken advantage of by companies that charge hidden fees.
Under this legislation, companies would be required to clearly disclose any additional fees or charges that may not be readily apparent to consumers. This includes fees for services, products, or transactions that are not explicitly stated in the initial agreement or contract.
The Hidden Fee Disclosure Act of 2023 also mandates that companies provide consumers with a breakdown of all fees associated with a particular product or service, as well as information on how these fees are calculated. This information must be presented in a clear and easily understandable manner, so that consumers can make informed decisions about their purchases. Overall, this bill seeks to empower consumers by giving them the information they need to make educated choices about their financial transactions. By increasing transparency and accountability in the financial industry, the Hidden Fee Disclosure Act of 2023 aims to protect consumers from being unfairly charged hidden fees.
Under this legislation, companies would be required to clearly disclose any additional fees or charges that may not be readily apparent to consumers. This includes fees for services, products, or transactions that are not explicitly stated in the initial agreement or contract.
The Hidden Fee Disclosure Act of 2023 also mandates that companies provide consumers with a breakdown of all fees associated with a particular product or service, as well as information on how these fees are calculated. This information must be presented in a clear and easily understandable manner, so that consumers can make informed decisions about their purchases. Overall, this bill seeks to empower consumers by giving them the information they need to make educated choices about their financial transactions. By increasing transparency and accountability in the financial industry, the Hidden Fee Disclosure Act of 2023 aims to protect consumers from being unfairly charged hidden fees.
Read the Full Bill
Current Status of Bill HR 4508
Bill HR 4508 is currently in the status of Bill Introduced since July 10, 2023. Bill HR 4508 was introduced during Congress 118 and was introduced to the House on July 10, 2023. Bill HR 4508's most recent activity was Placed on the Union Calendar, Calendar No. 209. as of November 1, 2023
Bipartisan Support of Bill HR 4508
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
2Democrat Cosponsors
0Republican Cosponsors
2Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 4508
Primary Policy Focus
HealthAlternate Title(s) of Bill HR 4508
Hidden Fee Disclosure Act of 2023
Hidden Fee Disclosure Act of 2023
Hidden Fee Disclosure Act
To amend the Employee Retirement Income Security Act of 1974 to clarify and strengthen the application of certain employer-sponsored health plan disclosure requirements.
Comments
Sponsors and Cosponsors of HR 4508
Latest Bills
Keep It Moving Act
Bill HR 7742March 13, 2026
Stop ICE Intimidation Act of 2026
Bill HR 7743March 13, 2026
African American History Act of 2026
Bill HR 7740March 13, 2026
Rural and Underserved Health Care Staffing Act
Bill HR 7686March 13, 2026
Fight Book Bans Act
Bill HR 7691March 13, 2026
Dr. William W. Sullivan TRIO Upward Bound Student Stipend Support Act
Bill HR 7690March 13, 2026
Gun Owner Registration Information Protection Act
Bill S 3916March 13, 2026
Global Investment in American Jobs Act of 2025
Bill S 2563March 13, 2026
Making further consolidated appropriations for the fiscal year ending September 30, 2026, and for other purposes.
Bill HR 7147March 13, 2026
A bill to provide that the approved application under the Federal Food, Drug, and Cosmetic Act for the drug mifepristone for the purpose of the termination of intrauterine pregnancy is deemed to have been withdrawn, to establish a Federal tort for harm to women caused by chemical abortion drugs, and for other purposes.
Bill S 4066March 13, 2026
Lower Costs, More Transparency Act
Bill HR 5378February 6, 2024

